HSIC Henry Schein, Inc. - Common Stock
NASDAQ · Health Care · Lihat di SEC EDGAR ↗ tutup Okt 2, 2026 10-K/10-Q Agu 4, 2026HSIC Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu
HSIC Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
Granularitas batang menyesuaikan dengan periode yang dipilih — arahkan kursor ke bagan untuk melihat buka/tinggi/rendah/tutup untuk sebuah batang.
| Tanggal ex-dividen | Pemecahan | Tipe |
|---|---|---|
| 8 Feb. 2019 | 51-for-40 | Maju |
| 15 Sep. 2017 | 2-for-1 | Maju |
| 1 Maret 2005 | 2-for-1 | Maju |
Tentang Henry Schein, Inc. - Common Stock Tinjauan perusahaan dari Wikipedia
Henry Schein, Inc. is an American distributor of health care products and services, with operations in 33 countries and territories. It is the world's largest provider of health care solutions to office-based dental and medical practitioners.
History
In 1932, Henry Schein, a graduate of Columbia University College of Pharmacy, borrowed $500 and opened a pharmacy in Queens, New York. The company expanded into dental supplies in the 1960s, and by the late 1980s, Henry Schein held approximately 10 percent of the dental-supply market. Marvin Schein, Henry Schein's son, took over management of daily operations in 1971.
In 1978, founder Henry Schein's son Jay Schein became CEO of the company. When Jay Schein died of cancer in 1989, Stanley Bergman took over as CEO. Bergman was born in South Africa and came to New York in 1976, where he became an accountant. In 1980, he joined Henry Schein and was promoted to CFO.
Henry Schein Inc. filed with the U.S. Securities and Exchange Commission in 1995 to sell 6.2 million shares in an initial public offering with William Blair & Company as the lead underwriter. The IPO raised $72.8 million and began trading on the Nasdaq. By 1996, the company was up to $1.4 billion in sales and $29 million in profit under Bergman's leadership. That year, the company made seventeen acquisitions.
In August 1997, Henry Schein Inc. agreed to buy Sullivan Dental Products Inc. for approximately $318 million. The purchase made the company the world's largest distributor of dental equipment and supplies. By that point, Henry Schein had made 16 acquisitions in 1997. Also in 1997, Henry Schein acquired New York-based medical-products distributor Micro BioMedics Inc as well as Dentrix Dental Systems.
Henry Schein announced the acquisition of demedis GmbH and Euro Dental Holding GmbH in June 2004. In November 2009, it was announced that Henry Schein Inc. and Butler Animal Health Supply would be launching joint venture Butler Schein Animal Health, the largest veterinary sales and distribution company in the United States. Butler Schein Animal Health was rebranded as Henry Schein Animal Health in 2013. Between 1989 and 2016, Henry Schein purchased approximately 200 companies. The company's chief executive officer, Stanley Bergman, was announced as Chief Executive Magazine's CEO of the Year in May 2017.
In 2018, the FTC accused Benco Dental, Patterson Companies, and Henry Schein of violating antitrust laws. In October 2019, the FTC's Chief Administrative Law Judge dismissed the claims against Henry Schein while finding that Benco and Patterson violated U.S. antitrust laws.
In February 2019, Henry Schein spun off the company's animal health business and merged it with Vets First Choice to form a new company. The new company is established as Covetrus.
Henry Schein Inc. was one of the six main defendants in lawsuits with state and local governments of the opioid epidemic in the United States. The company was dismissed as a defendant in October 2019 in the bellwether Summit County, Ohio litigation.
In July 2022, Henry Schein acquired Condor Dental, a dental distribution company.
In April 2023, Henry Schein acquired Biotech Dental, a provider of dental implants, clear aligners, and digital dental software, based in Salon-de-Provence, France.
In July 2023, Henry Schein acquired S.I.N Implant System, a major provider of dental implants in Brazil.
On October 14, 2023, Henry Schein reported a major hack into its core systems, which included investor information, and payroll data - amounting to 35 Terabytes of data being exfiltrated from the company. This resulted in its applications and e-commerce site being unavailable for several days.
In July 2025, Henry Schein announced that Stanley Bergman would be stepping down as CEO at the end of 2025, however he will continue to serve as chairman of the board. In January 2026 the company announced Bergman's successor as Frederick Lowery, Executive Vice President and President, Laboratory Products and BioProduction at Thermo Fisher Scientific.
In 2025, Henry Schein ranked 333rd by revenue on the Fortune 500 list and 34th within the healthcare sector.
Operations
Dental
In 1997, Henry Schein acquired Sullivan Dental Products and Dentrix Dental Systems, making it the world's largest distributor of dental equipment and supplies.
Dentrix Ascend, is a cloud-based dental practice management software platform developed by Henry Schein One for dental offices. The software is accessible through a web browser and includes tools of scheduling, billing, patient records, imaging, and practice management.
Henry Schein established the Henry Schein Dental Business Institute in March 2015 to teach owners and operators of dental practices the fundamentals of business. The first class to complete the program graduated in March 2016. Henry Schein also launched the Henry Schein Digital Dentistry Program at Temple University's Maurice H. Kornberg School of Dentistry in 2016.
In May 2016, Henry Schein's entity Dentrix presented the DEXIS software's ability to integrate X-rays into a patient's chart. Zahn Dental, Henry Schein's laboratory supply business, acquired Custom Automated Prosthetics in June 2016. The acquisition enabled Henry Schein to expand its prosthetic offerings.
In August 2019, Henry Schein acquired a majority equity stake in Cliniclands, a distributor serving dental practices throughout Sweden, Denmark, and Norway.
In May 2021, Henry Schein announced it acquired an 80% ownership position in Jarvis Analytics, a software company that develops comprehensive data analytics tools for dental practitioners.
In June 2021, Henry Schein acquired a 70% ownership position in eAssist Dental Solutions (eAssist), the developer of a virtual dental billing outsourcing service.
In August 2022, Henry Schein acquired Midway Dental Supply, a full-service dental distributor serving across the Midwestern United States.
In January 2023, Henry Schein announced its subsidiary, eAssist Dental Solutions (eAssist), acquired a majority interest in Unitas PPO Solutions (Unitas), a service provider that works with dental practices to assess their commercial insurance participation, set competitive fee-for-service rates, and negotiate contracted reimbursement with commercial insurers.
In July 2024, Henry Schein acquired abc dental AG, a full-service dental distributor offering consumables, equipment, and technical service to general practitioners, specialists, and dental laboratories in Switzerland.
Henry Schein One
In July 2018, Henry Schein and Internet Brands completed a joint venture to form Henry Schein One. The new company delivers integrated dental technology to help improve practice management and marketing as well as patient communication. Since the formation, Henry Schein One has included Dentrix, Dentrix Ascend, Dentalplans.com, Demandforce, Sesame Communications, and Officite as part of its portfolio of dental technology products.
In July 2019, Henry Schein One acquired Elite Computer Italia S.r.L. (Elite), a full-service software company that delivers practice management solutions to dental practices in Italy.
In November 2022, Henry Schein One announced a partnership with VideaHealth, a dental AI platform. As a result, Henry Schein One introduced Dentrix Detect AI, an AI-enabled X-Ray analysis tool. The integration with VideaHealth's FDA-cleared computer-assisted detection (CADe) device can help oral health professionals use AI in dental practices.
In December 2023, Henry Schein One was named to Utah Business Magazine's Best Companies to Work For list.
Medical
In November 2014, Henry Schein Medical announced a strategic arrangement with Cardinal Health. Cardinal Health's physician office-sales organization consolidated into Henry Schein Medical.
In March 2019, Henry Schein acquired North American Rescue (NAR), the leading provider of survivability and casualty-care medical products to the defense and public-safety markets.
In January 2021, Henry Schein acquired a majority ownership position in Prism Medical Products, LLC (PRISM), a nationwide provider of specialty home medical supplies with a core competency in advanced wound care products.
In October 2023, Henry Schein acquired Shield Healthcare, Inc., a supplier of homecare medical products delivered directly to patients in their homes.
In April 2024, Henry Schein acquired TriMed, a developer of orthopedic devices for lower extremities (foot and ankle) and upper extremities (hand and wrist).
In January 2025, Henry Schein acquired all of the assets of Acentus, a medical supplier specializing in Continuous Glucose Monitors (CGMs).
Former division
Animal health
Henry Schein has spun off this division in early 2019 produces software that is used in veterinary practices designed to improve communication and data management including the online cloud-based application, Rapport. In February 2016, Henry Schein released Axis-Q, a software application designed to ease the recording and access of veterinary medical records.
Philanthropy
In 1998, Henry Schein's Back to School program was launched; this program provides underserved children with school supplies and has helped over 65,000 students since its foundation.
Since 1999, Henry Schein has held its annual ‘Holiday Cheer for Children’ program, which donates clothing, toys, and gift cards to over 20,000 children and their families throughout the holiday season.
In 2015, the Alpha Omega International Dental Society and Henry Schein Cares partnered to create the Alpha Omega-Henry Schein Cares Holocaust Survivors Oral Health Program, which offers pro bono oral care to Holocaust survivors. Since its inception, the program has provided treatment to over 1,600 individuals in the United States and Canada.
Since 2018, Henry Schein has supported the Special Olympics, in particular its Healthy Athletes program, through essential health care donations.
In April 2023, Henry Schein launched its Practice Green initiative, which seeks to encourage healthcare professionals to transition towards sustainable practices.
Henry Schein has also served as the exclusive product sponsor for the American Dental Association’s Give Kids A Smile Program. Henry Schein has contributed $20 million in oral health care products and more than 40,000 dental kits.
In April 2025, the Science Based Targets initiative (SBTi) approved Henry Schein's near-term and long-term science-based emissions reduction targets, verifying its net-zero science-based target by 2050.
Sumber: Wikipedia (English), CC BY-SA 4.0 · Lihat di Wikipedia ↗
Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS
Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?
| Metrik | Tren 5 Tahun | HSIC | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| P/E (TTM) | 24.7rata-rata 5T ≈21.5 | ≈21.5 | 22.9 | Terlalu mahal | |
| P/S (TTM) | 0.7rata-rata 5T ≈0.8 | ≈0.8 | 0.5 | Terlalu mahal | |
| P/B (MRQ) | 3.0rata-rata 5T ≈2.8 | ≈2.8 | · | · | |
| EV / EBITDA | 10.7rata-rata 5T ≈10.4 | ≈10.4 | · | · | |
| Harga / FCF (TTM) | 16.7rata-rata 5T ≈18.5 | ≈18.5 | · | · | |
| Harga / Arus Kas (TTM) | 13.6rata-rata 5T ≈14.8 | ≈14.8 | 14.0 | Nilai wajar | |
| EV / Revenue (EV / Pendapatan) | 0.8rata-rata 5T ≈0.8 | ≈0.8 | · | · | |
| EV / FCF | 18.0rata-rata 5T ≈18.9 | ≈18.9 | · | · | |
| Harga / Nilai Buku Berwujud (MRQ) | 4.3 | · | · | · | |
| PEG Ratio (Rasio PEG) | ≈8.2 | · | · | · |
Median rekan dihitung berdasarkan basis standar per metrik dan mungkin tidak selalu cocok dengan basis TTM/MRQ yang ditampilkan untuk saham ini.
Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC
| Metrik | Tren 5 Tahun | HSIC | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Margin Kotor (TTM) | 31.3%rata-rata 5T ≈30.8% | ≈30.8% | 4.3% | Tingkat teratas | |
| Margin Operasi (TTM) | 5.0%rata-rata 5T ≈5.5% | ≈5.5% | 1.1% | Tingkat teratas | |
| Margin EBITDA (TTM) | 7.4%rata-rata 5T ≈7.5% | ≈7.5% | 1.3% | Tingkat teratas | |
| Margin Sebelum Pajak (TTM) | 4.1%rata-rata 5T ≈5.0% | ≈5.0% | 1.0% | Tingkat teratas | |
| Margin Laba Bersih (TTM) | 3.0%rata-rata 5T ≈3.8% | ≈3.8% | 0.63% | Tingkat teratas | |
| ROA (TTM) | 3.6%rata-rata 5T ≈5.2% | ≈5.2% | 3.1% | Tingkat teratas | |
| ROE (TTM) | 12.2%rata-rata 5T ≈13.8% | ≈13.8% | -4.6% | Tingkat teratas | |
| ROIC | 12.4%rata-rata 5T ≈14.2% | ≈14.2% | 12.2% | Tingkat teratas |
Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca
| Metrik | Tren 5 Tahun | HSIC | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Utang / Ekuitas (MRQ) | 0.3rata-rata 5T ≈0.1 | ≈0.1 | 0.3 | Sejajar | |
| Rasio Lancar (MRQ) | 1.3rata-rata 5T ≈1.6 | ≈1.6 | 0.9 | Likuiditas kuat | |
| Quick Ratio (Rasio Cepat) | 0.6rata-rata 5T ≈0.7 | ≈0.7 | 0.5 | Likuiditas kuat | |
| Interest Coverage (Cakupan Bunga) | 4.4rata-rata 5T ≈12.8 | ≈12.8 | 5.9 | Likuiditas rendah |
Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T
| Metrik | Tren 5 Tahun | HSIC | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Revenue YoY (Pendapatan YoY) | 4.0%rata-rata 5T ≈5.8% | ≈5.8% | · | · | |
| Revenue CAGR 3Y (CAGR Pendapatan 3T) | 1.4%rata-rata 5T ≈3.0% | ≈3.0% | · | · | |
| Revenue CAGR 5Y (CAGR Pendapatan 5T) | 5.4% | · | · | · | |
| EPS YoY | 7.2%rata-rata 5T ≈6.0% | ≈6.0% | · | · | |
| Net Income YoY (Laba Bersih YoY) | 2.1%rata-rata 5T ≈2.9% | ≈2.9% | · | · | |
| EPS CAGR 3Y (CAGR EPS 3T) | -5.8%rata-rata 5T ≈-4.6% | ≈-4.6% | · | · | |
| EPS CAGR 5Y (CAGR EPS 5T) | 3.0% | · | · | · | |
| Net Income CAGR 3Y (CAGR Laba Bersih 3T) | -9.6%rata-rata 5T ≈-7.8% | ≈-7.8% | · | · | |
| Net Income CAGR 5Y (CAGR Laba Bersih 5T) | -0.30% | · | · | · |
Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang
| Metrik | Tren 5 Tahun | HSIC | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Asset Turnover (Perputaran Aset) | 1.2rata-rata 5T ≈1.3 | ≈1.3 | 4.5 | Lemah | |
| Inventory Turnover (Perputaran Persediaan) | 4.8rata-rata 5T ≈4.8 | ≈4.8 | 15.7 | Lemah | |
| Receivables Turnover (Perputaran Piutang) | 8.4rata-rata 5T ≈8.2 | ≈8.2 | 13.1 | Lemah | |
| Revenue / Employee (Pendapatan Tahunan ÷ karyawan (jumlah karyawan, yfinance). Turunan — bukan konsep SEC-XBRL yang tersimpan.) | ≈$527.4K | · | · | · |
nilai · ≈ rata-rata 5T · median industri · penilaian relatif terhadap median
Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya
| Periode | Laporan | EPS Aktual | EPS Estimasi | Kejutan |
|---|---|---|---|---|
| 30 Juni 2026 | Agu 11, 2026 | $1.27 | $1.26 | 0.67% |
| 31 Maret 2026 | Mei 12, 2026 | $1.32 | $1.24 | 6.3% |
| 31 Des. 2025 | $1.34 | $1.33 | 1.1% | |
| 30 Sep. 2025 | $1.38 | $1.30 | 5.8% | |
| 30 Juni 2025 | $1.10 | $1.22 | -9.5% | |
| 31 Maret 2025 | $1.15 | $1.13 | 1.6% |
Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas
Laporan Laba Rugi
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $13.18B | $12.67B | $12.34B | $12.65B | $12.40B | $10.12B | $9.99B | $9.42B | $8.88B | $11.57B | $10.63B | |
| Cost of Revenue | $9.08B | $8.66B | $8.48B | $8.82B | $8.73B | $7.30B | $6.89B | $6.51B | $6.14B | $8.35B | $7.62B | |
| Gross Profit | $4.11B | $4.02B | $3.86B | $3.83B | $3.67B | $2.82B | $3.09B | $2.91B | $2.75B | $3.23B | $3.01B | |
| SG&A Expense | $3.08B | $3.03B | $2.96B | $2.77B | $2.63B | $2.09B | $2.36B | $2.22B | $2.07B | $2.41B | $2.24B | |
| Operating Expenses | · | · | · | · | · | · | · | $2.70B | $2.53B | $2.41B | · | |
| Operating Income | $653M | $621M | $615M | $747M | $852M | $535M | $718M | $601M | $670M | $772M | $734M | |
| Interest Expense | $150M | $131M | $87M | $35M | $27M | $41M | $51M | $76M | $51M | $32M | $26M | |
| Interest Income | $33M | $24M | $17M | $8M | $6M | $10M | $16M | $15M | $12M | $13M | $13M | |
| Other Non-op | $-3M | $-1M | $-3M | $1M | $0 | $-4M | $-3M | $-3M | $-1M | $3M | $-141.0K | |
| Pretax Income | $533M | $513M | $542M | $721M | $831M | $500M | $680M | $537M | $630M | $756M | $721M | |
| Income Tax | $126M | $128M | $120M | $170M | $198M | $95M | $160M | $107M | $309M | $218M | $211M | |
| Net Income | $398M | $390M | $416M | $538M | $631M | $404M | $695M | $536M | $406M | $507M | $479M | |
| EPS (Basic) | $3.29 | $3.07 | $3.18 | $3.95 | $4.51 | $2.83 | $4.70 | $3.51 | $2.59 | $3.14 | $2.89 | |
| EPS (Diluted) | $3.27 | $3.05 | $3.16 | $3.91 | $4.45 | $2.82 | $4.65 | $3.49 | $2.57 | $3.10 | $2.85 | |
| Shares (Basic) | 120,813,977 | 126,788,997 | 130,618,990 | 136,064,221 | 140,090,889 | 142,504,193 | 147,817,000 | 152,656,000 | 156,787,000 | 161,641,000 | 165,687,000 | |
| Shares (Diluted) | 121,717,876 | 127,779,228 | 131,748,171 | 137,755,670 | 141,772,781 | 143,403,682 | 149,257,000 | 153,707,000 | 158,208,000 | 163,723,000 | 168,250,000 | |
| EBITDA | $964M | $918M | $863M | $959M | $1.06B | $721M | $903M | $961M | · | $941M | $893M |
Neraca
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $156M | $122M | $171M | $117M | $118M | $421M | · | $57M | $158M | $62M | $72M | |
| Receivables | $1.65B | $1.48B | $1.86B | $1.44B | $1.45B | $1.42B | $1.25B | $1.17B | $1.52B | $1.25B | $1.23B | |
| Inventory | $2.00B | $1.81B | $1.81B | $1.96B | $1.86B | $1.51B | $1.43B | $1.42B | $1.93B | $1.67B | $1.51B | |
| Prepaid Expense | $655M | $569M | $639M | $466M | $413M | $433M | $445M | $451M | $455M | $361M | $361M | |
| Current Assets | $4.46B | $3.98B | $4.49B | $3.99B | $3.84B | $3.79B | $3.23B | $4.18B | $4.09B | $3.34B | $3.23B | |
| PP&E (Net) | · | · | · | · | $366M | $342M | $330M | $314M | $375M | $334M | $318M | |
| PP&E (Gross) | $1.38B | $1.20B | $1.17B | $956M | $916M | $868M | $799M | $905M | $990M | $865M | $797M | |
| Accum. Depreciation | $759M | $670M | $672M | $573M | $550M | $526M | $469M | $591M | $615M | $531M | $478M | |
| Goodwill | $4.21B | $3.89B | $3.88B | $2.89B | $2.85B | $2.50B | $2.46B | $2.08B | $1.55B | $2.02B | $1.91B | |
| Intangibles | $1.02B | $1.02B | $916M | $587M | $668M | $479M | $573M | $376M | $670M | $621M | $593M | |
| Total Assets | $11.21B | $10.22B | $10.57B | $8.61B | $8.48B | $7.77B | $7.15B | $8.50B | $7.86B | $6.81B | $6.53B | |
| Accounts Payable | $1.15B | $962M | $1.02B | $1.00B | $1.05B | $1.01B | $880M | $786M | $1.15B | $1.01B | $1.01B | |
| Short-term Debt | $764M | $650M | $264M | $103M | $51M | $73M | $24M | $951M | · | · | · | |
| Current Liabilities | $3.23B | $2.80B | $2.68B | $2.22B | $2.31B | $2.28B | $2.04B | $3.22B | $2.83B | $2.32B | $2.15B | |
| Capital Leases | $251M | $259M | $310M | $275M | $268M | $239M | $176M | $0 | · | · | · | |
| Deferred Tax | $146M | $102M | $54M | $36M | $42M | $30M | $65M | $27M | $50M | $52M | $253M | |
| Other Non-current Liabilities | $486M | $387M | $436M | $361M | $377M | $393M | $331M | $358M | $420M | $264M | $212M | |
| Total Liabilities | $6.42B | $5.38B | $5.42B | $3.94B | $3.81B | $3.46B | $3.23B | $4.65B | $4.21B | $3.35B | $3.08B | |
| Long-term Debt | · | · | · | $1.05B | $822M | · | · | · | · | · | · | |
| Total Debt | $764M | $650M | $264M | $103M | $51M | $73M | $24M | · | · | · | · | |
| Paid-in Capital | $177M | $0 | $0 | $0 | $0 | $0 | $48M | $0 | · | · | · | |
| Retained Earnings | $3.29B | $3.77B | $3.86B | $3.68B | $3.60B | $3.45B | $3.12B | $3.21B | $2.94B | $2.98B | $2.90B | |
| AOCI | $-226M | $-379M | $-206M | $-233M | $-171M | $-108M | $-167M | $-249M | $-130M | $-317M | $-220M | |
| Stockholders' Equity | $3.25B | $3.39B | $3.65B | $3.45B | $3.42B | $3.35B | $3.00B | $2.96B | $2.81B | $2.79B | $2.88B | |
| Liabilities + Equity | $11.21B | $10.22B | $10.57B | $8.61B | $8.48B | $7.77B | $7.15B | $8.50B | $7.86B | $6.76B | $6.50B | |
| Shares Outstanding | 115,771,149 | 124,155,884 | 129,247,765 | 131,792,817 | 137,145,558 | 142,462,571 | 143,353,459 | 151,401,668 | 153,690,146 | 158,805,010 | 164,830,640 |
Arus Kas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $311M | $297M | $248M | $212M | $210M | $186M | $185M | $144M | $134M | $170M | $159M | |
| Stock-based Comp | $39M | $39M | $39M | $54M | $78M | $9M | $45M | $33M | $37M | $58M | $45M | |
| Deferred Tax | $5M | $-61M | $-20M | $-73M | $-11M | $-53M | $-4M | $-25M | $1M | $-37M | $-6M | |
| Amort. of Intangibles | $180M | $185M | $152M | $126M | $124M | $106M | $108M | $75M | $70M | $98M | $93M | |
| Restructuring | $105M | $110M | $80M | $128M | $8M | · | · | $54M | $0 | $46M | $35M | |
| Other Non-cash | $-41M | $183M | $-183M | $-129M | $-199M | $54M | $-266M | $-54M | · | $-82M | $-90M | |
| Operating Cash Flow | $712M | $848M | $500M | $602M | $710M | $599M | $654M | $685M | $546M | $643M | $616M | |
| CapEx | $139M | $148M | $147M | $96M | $79M | $49M | $76M | $71M | $62M | $70M | $72M | |
| Investing Cash Flow | $-400M | $-430M | $-1.14B | $-276M | $-677M | $-115M | $-424M | $-193M | $-342M | $-316M | $-260M | |
| Debt Issued | $489M | $120M | $1.37B | $270M | $305M | $501M | $741.0K | $115M | $200M | $261M | $135M | |
| Net Debt Issued | $445M | $-198M | $900M | $211M | $183M | $-110M | $-260M | $87M | · | $245M | $-66M | |
| Stock Issued | $250M | $0 | $0 | · | · | · | · | · | · | · | · | |
| Stock Repurchased | $850M | $385M | $250M | $485M | $401M | $74M | $525M | $200M | $450M | $550M | $300M | |
| Net Stock Activity | $-600M | $-385M | $-250M | $-485M | $-401M | $-74M | $-525M | $-200M | · | $-550M | $-300M | |
| Financing Cash Flow | $-188M | $-510M | $701M | $-315M | $-333M | $-187M | $-216M | $-604M | $-113M | $-327M | $-348M | |
| Net Change in Cash | $34M | $-49M | $54M | $-1M | $-303M | $315M | $26M | $-94M | $225M | $-10M | $-17M | |
| Taxes Paid | $128M | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $573M | $700M | $353M | $506M | $631M | $550M | $578M | $594M | · | $545M | $515M | |
| Levered FCF | $458M | $602M | $285M | $472M | $610M | $517M | $539M | $533M | · | $523M | $497M |
Profitabilitas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 31.1% | 31.7% | 31.3% | 30.3% | 29.6% | 27.8% | 30.9% | 27.2% | · | 28.0% | 28.3% | |
| Operating Margin | 5.0% | 4.9% | 5.0% | 5.9% | 6.9% | 5.3% | 7.2% | 5.7% | · | 6.7% | 6.9% | |
| Net Margin | 3.0% | 3.1% | 3.4% | 4.2% | 5.1% | 4.0% | 7.0% | 4.1% | · | 4.4% | 4.5% | |
| Pretax Margin | 4.0% | 4.0% | 4.4% | 5.7% | 6.7% | 4.9% | 6.8% | 5.3% | · | 6.5% | 6.8% | |
| EBITDA Margin | 7.3% | 7.2% | 7.0% | 7.6% | 8.6% | 7.1% | 9.0% | 7.3% | · | 8.1% | 8.4% | |
| ROA | 3.7% | 3.8% | 4.3% | 6.3% | 7.8% | 5.4% | 8.9% | 6.6% | · | 7.6% | 7.6% | |
| ROE | 12.0% | 11.1% | 11.7% | 15.7% | 18.6% | 12.7% | 23.3% | 18.6% | · | 17.8% | 16.8% | |
| ROIC | 12.4% | 11.5% | 12.2% | 16.1% | 18.7% | 12.7% | 18.2% | 19.7% | · | 19.7% | 18.0% |
Likuiditas & Solvabilitas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.4 | 1.4 | 1.7 | 1.8 | 1.7 | 1.7 | 1.6 | 1.3 | · | 1.4 | 1.5 | |
| Quick Ratio | 0.6 | 0.6 | 0.8 | 0.7 | 0.7 | 0.6 | 0.6 | 0.5 | · | 0.6 | 0.6 | |
| Debt / Equity | 0.2 | 0.2 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | · | · | · | · | |
| Interest Coverage | 4.4 | 4.7 | 7.1 | 17.0 | 30.9 | 12.9 | 14.1 | 9.6 | · | 24.2 | 28.2 |
Efisiensi
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.2 | 1.2 | 1.3 | 1.5 | 1.5 | 1.4 | 1.3 | 1.6 | · | 1.7 | 1.7 | |
| Inventory Turnover | 4.8 | 4.8 | 4.5 | 4.6 | 5.2 | 5.0 | 4.8 | 4.9 | · | 5.3 | 5.4 | |
| Receivables Turnover | 8.4 | 7.6 | 7.5 | 8.7 | 8.6 | 7.6 | 8.3 | 8.4 | · | 9.3 | 9.0 |
Per Saham
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $28.03 | $27.33 | $28.28 | $26.15 | $24.97 | $23.50 | $20.91 | $19.56 | · | $35.18 | $35.00 | |
| Revenue / Share | $108.32 | $99.18 | $93.66 | $91.81 | $87.47 | $70.56 | $66.90 | $85.89 | · | $141.36 | $126.36 | |
| Cash Flow / Share | $5.85 | $6.64 | $3.80 | $4.37 | $5.00 | $4.18 | $4.38 | $4.45 | · | $7.52 | $6.98 | |
| Cash / Share | $1.35 | $0.98 | $1.32 | $0.89 | $0.86 | · | · | $0.53 | · | $0.79 | $0.87 | |
| EPS (TTM) | $3.27 | $3.05 | $3.16 | $3.91 | $4.45 | $2.82 | $4.65 | $3.49 | · | $3.10 | $2.85 |
Tingkat Pertumbuhan
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 4.0% | 2.7% | -2.4% | 2.0% | 22.6% | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 1.4% | 0.73% | 6.8% | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 5.4% | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 7.2% | -3.5% | -19.2% | -12.1% | 57.8% | · | · | · | · | · | · | |
| EPS CAGR 3Y | -5.8% | -11.8% | 3.9% | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 3.0% | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 2.1% | -6.2% | -22.7% | -14.7% | 56.2% | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -9.6% | -14.8% | 0.98% | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -0.30% | · | · | · | · | · | · | · | · | · | · |
Valuasi (TTM)
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $13.18B | $12.67B | $12.34B | $12.65B | $12.40B | $10.12B | $9.99B | $9.42B | · | $11.57B | $10.63B | |
| Net Income TTM | $398M | $390M | $416M | $538M | $631M | $404M | $695M | $536M | · | $507M | $479M | |
| Market Cap | $8.81B | $8.74B | $9.79B | $10.53B | $10.28B | $9.38B | $9.54B | $9.25B | · | $4.72B | $5.08B | |
| Enterprise Value | $9.42B | $9.27B | $9.88B | $10.51B | $10.21B | · | · | · | · | · | · | |
| P/E | 23.3 | 23.1 | 24.0 | 20.4 | 16.8 | 23.3 | 14.3 | 17.5 | · | 19.2 | 21.6 | |
| P/S | 0.7 | 0.7 | 0.8 | 0.8 | 0.8 | 0.9 | 1.0 | 1.0 | · | 0.4 | 0.5 | |
| P/B | 2.7 | 2.6 | 2.7 | 3.1 | 3.0 | 2.8 | 3.2 | 3.1 | · | 1.7 | 1.8 | |
| P / Tangible Book | · | · | · | · | · | 25.7 | · | · | · | · | · | |
| P / Cash Flow | 12.4 | 10.3 | 19.6 | 17.5 | 14.5 | 15.7 | 14.6 | 13.5 | · | 7.7 | 8.7 | |
| P / FCF | 15.4 | 12.5 | 27.7 | 20.8 | 16.3 | 17.0 | 16.5 | 15.6 | · | 8.7 | 9.9 | |
| EV / EBITDA | 9.8 | 10.1 | 11.4 | 11.0 | 9.6 | · | · | · | · | · | · | |
| EV / FCF | 16.4 | 13.2 | 28.0 | 20.8 | 16.2 | · | · | · | · | · | · | |
| EV / Revenue | 0.7 | 0.7 | 0.8 | 0.8 | 0.8 | · | · | · | · | · | · | |
| Earnings Yield | 4.3% | 4.3% | 4.2% | 4.9% | 5.9% | 4.3% | 7.0% | 5.7% | · | 5.2% | 4.6% |
Laporan Laba Rugi
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.46B | $3.37B | $3.44B | $3.34B | $3.24B | $3.17B | $3.19B | $3.17B | $3.14B | $3.17B | $3.02B | $3.16B | $3.06B | $3.37B | $3.07B | |
| Cost of Revenue | $2.36B | $2.30B | $2.37B | $2.31B | $2.22B | $2.17B | $2.20B | $2.18B | $2.12B | $2.16B | $2.09B | $2.17B | $2.09B | $2.37B | $2.15B | |
| Gross Profit | $1.10B | $1.07B | $1.06B | $1.03B | $1.02B | $1.00B | $993M | $993M | $1.02B | $1.01B | $924M | $995M | $966M | $999M | $914M | |
| SG&A Expense | $831M | $809M | $808M | $760M | $778M | $738M | $738M | $724M | $781M | $791M | $807M | $725M | $717M | $761M | $648M | |
| Operating Income | $171M | $182M | $163M | $164M | $151M | $175M | $155M | $157M | $159M | $150M | $39M | $200M | $175M | $72M | $211M | |
| Interest Expense | $43M | $39M | $39M | $38M | $38M | $35M | $35M | $34M | $32M | $30M | $29M | $25M | $14M | $12M | $8M | |
| Interest Income | $8M | $7M | $9M | $9M | $9M | $6M | $6M | $7M | $6M | $5M | $5M | $6M | $3M | $3M | $1M | |
| Other Non-op | $1M | $0 | $0 | $-1M | $-1M | $-1M | $0 | $-2M | $-1M | $2M | $-1M | $-2M | $-1M | $0 | $1M | |
| Pretax Income | $137M | $150M | $133M | $134M | $121M | $145M | $126M | $128M | $132M | $127M | $14M | $179M | $163M | $63M | $205M | |
| Income Tax | $34M | $38M | $32M | $28M | $31M | $35M | $31M | $32M | $33M | $32M | $1M | $39M | $39M | $15M | $46M | |
| Net Income | $94M | $107M | $101M | $101M | $86M | $110M | $94M | $99M | $104M | $93M | $18M | $137M | $121M | $47M | $150M | |
| EPS (Basic) | $0.83 | $0.93 | $0.85 | $0.84 | $0.71 | $0.89 | $0.75 | $0.79 | $0.81 | $0.72 | $0.14 | $1.06 | $0.92 | $0.37 | $1.10 | |
| EPS (Diluted) | $0.82 | $0.92 | $0.85 | $0.84 | $0.70 | $0.88 | $0.75 | $0.78 | $0.80 | $0.72 | $0.14 | $1.05 | $0.91 | $0.36 | $1.09 | |
| Shares (Basic) | 113,451,329 | 114,939,640 | · | 120,199,552 | 121,927,867 | 123,776,073 | · | 126,124,715 | 127,784,380 | 128,720,661 | · | 130,388,353 | 131,365,789 | · | 135,608,678 | |
| Shares (Diluted) | 114,390,366 | 116,061,244 | · | 121,036,247 | 122,636,948 | 124,848,221 | · | 127,054,934 | 128,646,506 | 129,769,580 | · | 131,442,135 | 133,039,886 | · | 137,084,049 | |
| EBITDA | $255M | $263M | · | $244M | $151M | $248M | · | $157M | $159M | $223M | · | $200M | $227M | · | $211M |
Neraca
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $157M | $138M | $156M | $136M | $145M | $127M | $122M | $126M | $138M | $159M | · | $166M | $126M | · | · | |
| Receivables | $1.76B | $1.72B | $1.65B | $1.74B | $1.65B | $1.58B | $1.48B | $1.66B | $1.56B | $1.64B | $1.86B | $1.57B | $1.47B | $1.44B | $1.51B | |
| Inventory | $2.06B | $2.01B | $2.00B | $1.91B | $1.91B | $1.84B | $1.81B | $1.75B | $1.66B | $1.69B | · | $1.83B | $1.92B | · | $1.82B | |
| Prepaid Expense | $621M | $625M | $655M | $604M | $545M | $490M | $569M | $607M | $587M | $589M | · | $541M | $438M | · | $509M | |
| Current Assets | $4.60B | $4.50B | $4.46B | $4.39B | $4.24B | $4.04B | $3.98B | $4.15B | $3.94B | $4.08B | · | $4.11B | $3.95B | · | $3.96B | |
| PP&E (Gross) | · | · | $1.38B | · | · | · | $1.20B | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $759M | · | · | · | $670M | · | · | · | · | · | · | · | · | |
| Goodwill | $4.27B | $4.28B | $4.21B | $4.15B | $4.08B | $3.96B | $3.89B | $3.99B | $3.90B | $3.83B | $3.88B | $3.60B | $2.92B | $2.89B | $2.87B | |
| Intangibles | $965M | $1.01B | $1.02B | $1.05B | $1.04B | $1.03B | $1.02B | $1.10B | $1.08B | $915M | · | $834M | $548M | · | $635M | |
| Total Assets | $11.38B | $11.30B | $11.21B | $11.10B | $10.91B | $10.48B | $10.22B | $10.61B | $10.25B | $10.14B | · | $9.81B | $8.57B | · | $8.53B | |
| Accounts Payable | $1.14B | $1.04B | $1.15B | $1.03B | $918M | $908M | $962M | $1.03B | $867M | $879M | · | $953M | $855M | · | $957M | |
| Short-term Debt | $1.02B | $1.05B | $764M | $913M | $901M | $867M | $650M | $638M | $505M | $264M | · | $12M | $236M | · | $107M | |
| Current Liabilities | $3.49B | $3.30B | $3.23B | $3.15B | $3.01B | $2.92B | $2.80B | $2.93B | $2.55B | $2.33B | · | $2.09B | $2.17B | · | $2.15B | |
| Capital Leases | $275M | $263M | $251M | $264M | $259M | $256M | $259M | $262M | $261M | $266M | · | $314M | $274M | · | $271M | |
| Deferred Tax | $153M | $158M | $146M | $144M | $147M | $135M | $102M | $123M | $115M | $77M | · | $91M | $40M | · | $37M | |
| Other Non-current Liabilities | $442M | $437M | $486M | $487M | $504M | $485M | $387M | $414M | $431M | $423M | · | $396M | $368M | · | $338M | |
| Total Liabilities | $6.66B | $6.48B | $6.42B | $6.20B | $6.01B | $5.76B | $5.38B | $5.63B | $5.25B | $5.11B | · | $4.71B | $3.88B | · | $3.73B | |
| Total Debt | $1.02B | $1.05B | · | $913M | $901M | $867M | · | $638M | $505M | $264M | · | $12M | · | · | $107M | |
| Paid-in Capital | $140M | $167M | $177M | $207M | $186M | $0 | $0 | $0 | $0 | $0 | · | $0 | $0 | · | $0 | |
| Retained Earnings | $3.20B | $3.29B | $3.29B | $3.38B | $3.48B | $3.63B | $3.77B | $3.77B | $3.80B | $3.84B | · | $3.90B | $3.68B | · | $3.92B | |
| AOCI | $-184M | $-189M | $-226M | $-222M | $-227M | $-317M | $-379M | $-264M | $-292M | $-239M | $-206M | $-247M | $-213M | $-233M | $-312M | |
| Stockholders' Equity | $3.16B | $3.27B | $3.25B | $3.36B | $3.44B | $3.31B | $3.39B | $3.50B | $3.51B | $3.60B | · | $3.65B | $3.47B | · | $3.61B | |
| Liabilities + Equity | $11.38B | $11.30B | $11.21B | $11.10B | $10.91B | $10.48B | $10.22B | $10.61B | $10.25B | $10.14B | · | $9.81B | $8.57B | · | $8.53B | |
| Shares Outstanding | 111,916,222 | 114,424,682 | 115,771,149 | 118,567,917 | 121,895,045 | 122,243,683 | 124,155,884 | 125,154,194 | 127,080,545 | 128,480,909 | 129,247,765 | 129,935,883 | 131,196,783 | 131,792,817 | 135,258,887 |
Arus Kas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $84M | $81M | $82M | $80M | $76M | $73M | $76M | $74M | $74M | $73M | $68M | $69M | $52M | $52M | $52M | |
| Stock-based Comp | $13M | $3M | $10M | $13M | $11M | $5M | $9M | $10M | $12M | $8M | $1M | $14M | $10M | $10M | $17M | |
| Deferred Tax | $-10M | $2M | $5M | $7M | $0 | $-7M | $-20M | $-22M | $-21M | $2M | $-16M | $-1M | $2M | $-53M | $-5M | |
| Restructuring | $29M | $12M | $23M | $34M | $23M | $25M | $37M | $48M | $15M | $10M | · | $11M | $30M | · | $9M | |
| Other Non-cash | · | $-290M | · | · | · | $-144M | · | · | · | $21M | · | · | $-158M | · | · | |
| Operating Cash Flow | $242M | $-97M | $381M | $174M | $120M | $37M | $204M | $151M | $296M | $197M | $-32M | $231M | $27M | $254M | $98M | |
| CapEx | $30M | $25M | $43M | $33M | $32M | $31M | $36M | $34M | $37M | $41M | $39M | $40M | $31M | $29M | $24M | |
| Investing Cash Flow | $-65M | $-63M | $-147M | $-56M | $-98M | $-99M | $-58M | $-91M | $-209M | $-72M | $-327M | $-468M | $-39M | $-65M | $-152M | |
| Debt Issued | $87M | $57M | $175M | $70M | $94M | $150M | $0 | $30M | $0 | $90M | $210M | $750M | $31M | $105M | $165M | |
| Net Debt Issued | · | $18M | · | · | · | $135M | · | · | · | $30M | · | · | $30M | · | · | |
| Stock Issued | · | · | $0 | $0 | · | · | $0 | $0 | · | · | · | · | · | · | · | |
| Stock Repurchased | $200M | $125M | $200M | $203M | $286M | $161M | $75M | $135M | $100M | $75M | $50M | $50M | $100M | $285M | $90M | |
| Net Stock Activity | · | $-125M | · | · | · | $-161M | · | · | · | $-75M | · | · | $-100M | · | · | |
| Financing Cash Flow | $-168M | $120M | $-206M | $-127M | $56M | $89M | $-204M | $-41M | $-114M | $-151M | $394M | $248M | $21M | $-194M | $74M | |
| Net Change in Cash | $19M | $-18M | $20M | $-9M | $18M | $5M | $-4M | $-12M | $-21M | $-12M | $5M | $29M | $9M | $-6M | $15M | |
| Free Cash Flow | · | $-122M | · | · | · | $6M | · | · | · | $156M | · | · | $-4M | · | · | |
| Levered FCF | · | $-151M | · | · | · | $-21M | · | · | · | $134M | · | · | $-15M | · | · |
Profitabilitas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 31.8% | 31.8% | · | 30.7% | 31.4% | 31.6% | · | 31.3% | 32.5% | 31.9% | · | 31.5% | 31.6% | · | 29.8% | |
| Operating Margin | 5.0% | 5.4% | · | 4.9% | 4.7% | 5.5% | · | 5.0% | 5.1% | 4.7% | · | 6.3% | 5.7% | · | 6.9% | |
| Net Margin | 2.7% | 3.2% | · | 3.0% | 2.6% | 3.5% | · | 3.1% | 3.3% | 2.9% | · | 4.3% | 4.0% | · | 4.9% | |
| Pretax Margin | 4.0% | 4.5% | · | 4.0% | 3.7% | 4.6% | · | 4.0% | 4.2% | 4.0% | · | 5.7% | 5.3% | · | 6.7% | |
| EBITDA Margin | 7.4% | 7.8% | · | 7.3% | 4.7% | 7.8% | · | 5.0% | 5.1% | 7.0% | · | 6.3% | 7.4% | · | 6.9% | |
| ROA | 0.84% | 0.98% | · | 0.93% | 0.81% | 1.1% | · | 0.97% | 1.1% | 0.99% | · | 1.5% | · | · | 1.8% | |
| ROE | 2.9% | 3.2% | · | 2.9% | 2.5% | 3.2% | · | 2.8% | 2.9% | 2.6% | · | 3.8% | · | · | 4.2% | |
| ROIC | 3.1% | 3.1% | · | 3.0% | 2.6% | 3.2% | · | 2.8% | 3.0% | 2.9% | · | 4.3% | · | · | 4.4% |
Likuiditas & Solvabilitas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.3 | 1.4 | · | 1.4 | 1.4 | 1.4 | · | 1.4 | 1.5 | 1.7 | · | 2.0 | · | · | 1.8 | |
| Quick Ratio | 0.6 | 0.6 | · | 0.6 | 0.6 | 0.6 | · | 0.6 | 0.7 | 0.8 | · | 0.8 | · | · | 0.7 | |
| Debt / Equity | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.2 | 0.1 | 0.1 | · | 0.0 | · | · | 0.0 | |
| Interest Coverage | 4.0 | 4.7 | · | 4.3 | 4.0 | 5.0 | · | 4.6 | 5.0 | 5.0 | · | 8.0 | 12.5 | · | 19.2 |
Efisiensi
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | · | · | 0.4 | |
| Inventory Turnover | 1.2 | 1.2 | · | 1.3 | 1.2 | 1.2 | · | 1.2 | 1.2 | 1.2 | · | 1.2 | · | · | 1.2 | |
| Receivables Turnover | 2.0 | 2.0 | · | 2.0 | 2.0 | 2.0 | · | 2.0 | 2.1 | 2.0 | · | 2.1 | · | · | 2.0 |
Per Saham
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $28.21 | $28.54 | · | $28.35 | $28.26 | $27.08 | · | $27.99 | $27.64 | $28.02 | · | $28.10 | · | · | $26.70 | |
| Revenue / Share | $30.23 | $29.02 | · | $27.59 | $26.42 | $25.37 | · | $24.98 | $24.38 | $24.44 | · | $24.06 | $23.00 | · | $22.37 | |
| Cash Flow / Share | · | $-0.84 | · | · | · | $0.30 | · | · | · | $1.52 | · | · | $0.20 | · | · | |
| Cash / Share | $1.40 | $1.21 | · | $1.15 | $1.19 | $1.04 | · | $1.01 | $1.09 | $1.24 | · | $1.28 | · | · | · | |
| EPS (TTM) | $3.43 | $3.31 | · | $3.17 | $3.11 | $3.21 | · | $2.44 | $2.71 | $2.97 | · | $3.38 | $3.52 | · | $4.59 |
Valuasi (TTM)
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $13.60B | $13.38B | · | $12.94B | $12.77B | $12.67B | · | $12.50B | $12.49B | $12.45B | · | $12.69B | $12.53B | · | $12.61B | |
| Net Income TTM | $403M | $395M | · | $391M | $389M | $407M | · | $314M | $352M | $388M | · | $445M | $478M | · | $638M | |
| Market Cap | $9.51B | $8.25B | · | $7.83B | $8.93B | $8.39B | · | $9.16B | $8.15B | $9.70B | · | $9.65B | · | · | $9.11B | |
| Enterprise Value | $10.37B | $9.16B | · | $8.61B | $9.69B | $9.13B | · | $9.68B | $8.51B | $9.81B | · | $9.49B | · | · | · | |
| P/E | 24.8 | 21.8 | · | 20.8 | 23.6 | 21.4 | · | 30.0 | 23.7 | 25.4 | · | 22.0 | 23.2 | · | 14.7 | |
| P/S | 0.7 | 0.6 | · | 0.6 | 0.7 | 0.7 | · | 0.7 | 0.7 | 0.8 | · | 0.8 | · | · | 0.7 | |
| P/B | 3.0 | 2.5 | · | 2.3 | 2.6 | 2.5 | · | 2.6 | 2.3 | 2.7 | · | 2.6 | · | · | 2.5 | |
| P / Tangible Book | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 85.9 | |
| P / Cash Flow | · | -85.1 | · | · | · | 226.7 | · | · | · | 49.3 | · | · | · | · | · | |
| EV / Revenue | 0.8 | 0.7 | · | 0.7 | 0.8 | 0.7 | · | 0.8 | 0.7 | 0.8 | · | 0.7 | · | · | · | |
| Earnings Yield | 4.0% | 4.6% | · | 4.8% | 4.2% | 4.7% | · | 3.3% | 4.2% | 3.9% | · | 4.5% | 4.3% | · | 6.8% |
Periode terbaru di sebelah kiri · nilai null ditampilkan sebagai ·
Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir
| Metrik | 2025-12-27 | 2024-12-28 | 2023-12-30 | 2022-12-31 | 2021-12-25 |
|---|---|---|---|---|---|
| Pendapatan | $13.18B | $12.67B | $12.34B | $12.65B | $12.40B |
| Margin Kotor % | 31.1% | 31.7% | 31.3% | 30.3% | 29.6% |
| Margin Operasi % | 5.0% | 4.9% | 5.0% | 5.9% | 6.9% |
| Laba Bersih | $398M | $390M | $416M | $538M | $631M |
| EPS Dilusian | $3.27 | $3.05 | $3.16 | $3.91 | $4.45 |
| Metrik | 2025-12-27 | 2024-12-28 | 2023-12-30 | 2022-12-31 | 2021-12-25 |
|---|---|---|---|---|---|
| Utang / Ekuitas | 0.2 | 0.2 | 0.1 | 0.0 | 0.0 |
| Rasio Lancar | 1.4 | 1.4 | 1.7 | 1.8 | 1.7 |
| Rasio Cepat | 0.6 | 0.6 | 0.8 | 0.7 | 0.7 |
| Metrik | 2025-12-27 | 2024-12-28 | 2023-12-30 | 2022-12-31 | 2021-12-25 |
|---|---|---|---|---|---|
| Arus Kas Bebas | $573M | $700M | $353M | $506M | $631M |
Pemilik institusional (13F) 600 pengaju · $11.2B total · Per tanggal 30 Sep. 2026
Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.
| Posisi baru | Posisi yang keluar | Meningkat | Menurun | Perubahan bersih saham |
|---|---|---|---|---|
| 64 (-16 vs Kuartal sebelumnya) | 60 (+14 vs Kuartal sebelumnya) | 173 (-3 vs Kuartal sebelumnya) | 220 (+25 vs Kuartal sebelumnya) | +9.1M |
Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.
| Institusi | Nilai | Saham | % dari 13F yang dilacak | Tipe |
|---|---|---|---|---|
| Kohlberg Kravis Roberts & Co. L.P. | $1.307.257.713 | 15.652.032 | 11,68% | Saham |
| VANGUARD GROUP INC | $875.836.080 | 11.588.199 | 7,82% | Saham |
| FMR LLC | $630.901.802 | 7.553.901 | 5,64% | Saham |
| BlackRock, Inc. | $586.699.894 | 7.024.663 | 5,24% | Saham |
| Artisan Partners Limited Partnership | $540.162.844 | 6.467.467 | 4,82% | Saham |
| VANGUARD CAPITAL MANAGEMENT LLC | $530.073.795 | 6.346.669 | 4,73% | Saham |
| JPMORGAN CHASE & CO | $366.432.667 | 4.342.929 | 3,27% | Saham |
| STATE STREET CORP | $359.576.652 | 4.305.276 | 3,21% | Saham |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $345.225.076 | 4.133.442 | 3,08% | Saham |
| AMERICAN CENTURY COMPANIES INC | $288.743.396 | 3.457.175 | 2,58% | Saham |
| DIMENSIONAL FUND ADVISORS LP | $283.495.786 | 3.394.242 | 2,53% | Saham |
| Southpoint Capital Advisors LP | $275.616.000 | 3.300.000 | 2,46% | Saham |
| Invesco Ltd. | $263.107.794 | 3.150.237 | 2,35% | Saham |
| CITADEL ADVISORS LLC | $243.970.523 | 2.921.103 | 2,18% | Saham |
| GEODE CAPITAL MANAGEMENT, LLC | $227.537.373 | 2.729.030 | 2,03% | Saham |
| Palestra Capital Management LLC | $204.347.632 | 2.446.691 | 1,83% | Saham |
| BANK OF MONTREAL /CAN/ | $176.687.394 | 2.115.510 | 1,58% | Saham |
| MORGAN STANLEY | $175.460.572 | 2.100.819 | 1,57% | Saham |
| FIDUCIARY MANAGEMENT INC /WI/ | $151.785.323 | 1.817.353 | 1,36% | Saham |
| Burgundy Asset Management Ltd. | $151.049.204 | 2.170.871 | 1,35% | Saham |
| LYRICAL ASSET MANAGEMENT LP | $122.553.156 | 1.467.351 | 1,09% | Saham |
| UBS Group AG | $111.653.127 | 1.336.843 | 1,00% | Saham |
| Swedbank AB | $109.479.854 | 1.310.822 | 0,98% | Saham |
| M.D. Sass, LLC | $107.485.396 | 1.286.942 | 0,96% | Saham |
| SNYDER CAPITAL MANAGEMENT L P | $107.341.992 | 1.285.225 | 0,96% | Saham |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $107.262.144 | 1.272.537 | 0,96% | Saham |
| NORGES BANK | $103.383.729 | 1.237.832 | 0,92% | Saham |
| BANK OF AMERICA CORP /DE/ | $101.266.079 | 1.212.477 | 0,90% | Saham |
| GOLDMAN SACHS GROUP INC | $98.070.544 | 1.174.216 | 0,88% | Saham |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $86.593.118 | 1.036.795 | 0,77% | Saham |
| NORTHERN TRUST CORP | $80.548.694 | 964.424 | 0,72% | Saham |
| NOMURA HOLDINGS INC | $77.065.658 | 922.721 | 0,69% | Saham |
| PZENA INVESTMENT MANAGEMENT LLC | $71.888.420 | 860.733 | 0,64% | Saham |
| DME Capital Management, LP | $60.013.296 | 718.550 | 0,54% | Saham |
| Ananym Capital Management, LP | $57.978.164 | 694.183 | 0,52% | Saham |
| Ulysses Management LLC | $55.570.700 | 665.358 | 0,50% | Saham |
| STALEY CAPITAL ADVISERS INC | $55.252.489 | 661.548 | 0,49% | Saham |
| VANGUARD FIDUCIARY TRUST CO | $45.489.502 | 544.654 | 0,41% | Saham |
| RAYMOND JAMES FINANCIAL INC | $42.948.907 | 514.235 | 0,38% | Saham |
| Bank of New York Mellon Corp | $42.261.071 | 505.999 | 0,38% | Saham |
| Nuveen, LLC | $38.262.099 | 458.119 | 0,34% | Saham |
| DEUTSCHE BANK AG\ | $36.574.075 | 437.908 | 0,33% | Saham |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $35.970.895 | 430.686 | 0,32% | Saham |
| Clarkston Capital Partners, LLC | $35.168.100 | 421.074 | 0,31% | Saham |
| LONE PEAK GLOBAL INVESTORS LLC | $33.404.158 | 399.954 | 0,30% | Saham |
| GAMCO INVESTORS, INC. ET AL | $30.537.668 | 365.633 | 0,27% | Saham |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $27.342.332 | 370.995 | 0,24% | Saham |
| PRIVATE MANAGEMENT GROUP INC | $27.285.483 | 326.694 | 0,24% | Saham |
| FRANKLIN RESOURCES INC | $25.575.244 | 306.217 | 0,23% | Saham |
| BNP PARIBAS FINANCIAL MARKETS | $25.194.142 | 301.654 | 0,23% | Saham |
Aktivis & pemilik 5%+ 2 saham
Investor yang mengajukan Jadwal 13D SEC — kepemilikan manfaat di atas 5% dengan niat untuk memengaruhi penerbit (kepemilikan aktivis, kampanye dewan, M&A). Setiap baris menunjukkan status terbaru yang diketahui dari posisi pengaju tersebut.
| Pengaju | Diajukan | Kepemilikan | Status | Tujuan | Pengajuan |
|---|---|---|---|---|---|
| KKR Hawaii Holdings L.P., KKR Hawaii Holdings GP LLC, KKR Hawaii Aggregator L.P., KKR Hawaii Aggregator GP LLC, KKR North America Fund XIII SCSp, KKR Associates North America XIII SCSp, KKR North America XIII S.a r.l., KKR North America XIII Holdings Limited, MH Sub I, LLC, Indigo Intermediate Co II, LLC, IB Aggregator II L.P., KKR Indigo Aggregator III GP LLC, KKR Americas Fund XII (Indigo) L.P., KKR Associates Americas XII AIV L.P., KKR Americas XII AIV GP LLC, KKR Group Partnership L.P., KKR Group Holdings Corp., KKR Group Co. Inc., KKR & Co. Inc., KKR Management LLP, Henry R. Kravis, George R. Roberts ×4 pengajuan | 10 Maret 2026 | 16,40% | Amandemen | · | SEC |
| KKR Hawaii Aggregator L.P., KKR Hawaii Aggregator GP LLC, KKR North America Fund XIII SCSp, KKR Associates North America XIII SCSp, KKR North America XIII S.a r.l., KKR North America XIII Holdings Limited, MH Sub I, LLC, Indigo Intermediate Co II, LLC, IB Aggregator II L.P., KKR Indigo Aggregator III GP LLC, KKR Americas Fund XII (Indigo) L.P., KKR Associates Americas XII AIV L.P., KKR Americas XII AIV GP LLC, KKR Group Partnership L.P., KKR Group Holdings Corp., KKR Group Co. Inc., KKR & Co. Inc., KKR Management LLP, Henry R. Kravis, George R. Roberts ×4 pengajuan | 8 Agu 2025 | 13,00% | Amandemen | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Orang dalam perusahaan 52 orang dalam · 25 pejabat · 22 direktur
| Orang Dalam | Peran | Aktivitas terakhir | Saham dimiliki | Beli 12m | Jual 12m | Bersih 12m |
|---|---|---|---|---|---|---|
| Andrea Albertini | CEO, Global Dist. & Tech. | 8 Sep. 2026 D | 116.104 | 0 | 0 | $0 |
| Thomas C Popeck | CEO, Henry Schein Products | 19 Maret 2026 S | 86.182 | 0 | 1 | $-98.630 |
| Frederick M. Lowery | CEO | 6 Maret 2026 A | 95.156 | 0 | 0 | $0 |
| Bradford C Connett | CEO, NA Distribution Group | 19 Maret 2025 S | 62.688 | 0 | 0 | $0 |
| David B Brous Jr | CEO, Strategic Business Group | 12 Juni 2023 S | 68.690 | 0 | 0 | $0 |
| Karen Prange | EVP&CEO Gl.AH.Med.Den.Sur.Grp | 2 Maret 2018 A | 62.902 | 0 | 0 | $0 |
| Lonnie Shoff | CEO, Global Strat Port Grp | 15 Maret 2016 S | 31.000 | 0 | 0 | $0 |
| Ronald N. South | SVP & Chief Financial Officer | 16 Maret 2026 F | 88.930 | 0 | 0 | $0 |
| James P Breslawski | President | 14 Maret 2025 D | 200.227 | 0 | 0 | $0 |
| Bridget A Ross | President, Global Medical Grp | 6 Maret 2017 A | 9.654 | 0 | 0 | $0 |
| Michael Zack | President of Int'l Group | 7 Maret 2013 M | 48.716 | 0 | 0 | $0 |
| Michael S Ettinger | EVP & Chief Operating Officer | 17 Maret 2026 G | 112.208 | 0 | 0 | $0 |
| Christine Zayac Sheehy | SVP, Chief Human Res. Officer | 16 Maret 2026 F | 18.454 | 0 | 0 | $0 |
| Mark E Mlotek | EVP, Chief Strategic Officer | 16 Maret 2026 F | 98.372 | 0 | 2 | $-478.758 |
| Walter Siegel | Sr. VP & Chief Legal Officer | 14 Maret 2025 D | 43.191 | 0 | 0 | $0 |
| Lorelei Mcglynn | SVP, Chief Human Res. Officer | 6 Sep. 2024 S | 71.833 | 0 | 0 | $0 |
| Gerald A Benjamin | EVP, Chief Admin. Officer | 26 Mei 2022 S | 95.616 | 0 | 0 | $0 |
| David Mckinley | CCO&Pres. Corp. Com. Dev. Grp. | 30 Nov. 2018 S | 68.012 | 0 | 0 | $0 |
| Paul Rose | SVP, Global Supply Chain | 6 Sep. 2017 S | 17.841 | 0 | 0 | $0 |
| Robert Minowitz | Pres., Int'l Dental Group EMEA | 12 Mei 2017 S | 22.943 | 0 | 0 | $0 |
| Michael Racioppi | SVP Chief Merchandising Offic. | 20 Maret 2017 M | 23.088 | 0 | 0 | $0 |
| Peter M. Mccarthy | Pres., Global Animal Health | 13 Maret 2017 S | 14.277 | 0 | 0 | $0 |
| James A. Harding | SVP, Chief Technology Officer | 8 Maret 2017 S | 16.589 | 0 | 0 | $0 |
| Stanley Komaroff | Senior Advisor | 2 Maret 2016 F | 25.144 | 0 | 0 | $0 |
| Leonard A David | SVP, Chief Compliance Officer | 17 Maret 2015 S | 12.343 | 0 | 0 | $0 |
| William K Daniel | Direktur | 12 Juni 2026 A | 7.641 | 1 | 0 | $691.900 |
| Scott Philip Serota | Direktur | 6 Maret 2026 A | 10.790 | 0 | 0 | $0 |
| Carole T Faig | Direktur | 6 Maret 2026 A | 8.025 | 0 | 0 | $0 |
| Anne H. Margulies | Direktur | 6 Maret 2026 A | 23.153 | 0 | 0 | $0 |
| Mohamad Ali | Direktur | 6 Maret 2026 A | 15.075 | 0 | 0 | $0 |
| Reed Vaughn Tuckson | Direktur | 6 Maret 2026 A | 12.520 | 0 | 0 | $0 |
| Robert J. Hombach | Direktur | 6 Maret 2026 A | 5.421 | 0 | 0 | $0 |
| Bradley T Sheares | Direktur | 6 Maret 2026 A | 47.623 | 0 | 0 | $0 |
| Philip A Laskawy | Direktur | 6 Maret 2026 A | 24.538 | 0 | 1 | $-228.544 |
| Carol Raphael | Direktur | 21 Mei 2025 F | 33.538 | 0 | 0 | $0 |
| Steven Paladino | Direktur | 4 Maret 2024 A | 138.272 | 0 | 0 | $0 |
| Dianne E Rekow | Direktur | 16 Maret 2022 A | 18.526 | 0 | 0 | $0 |
| Barry J Alperin | Direktur | 16 Maret 2022 A | 52.473 | 0 | 0 | $0 |
| Paul Brons | Direktur | 3 Maret 2021 F | 16.854 | 0 | 0 | $0 |
| Shira Goodman | Direktur | 3 Maret 2021 A | 5.689 | 0 | 0 | $0 |
| Lawrence S Bacow | Direktur | 6 Maret 2018 F | 10.115 | 0 | 0 | $0 |
| Donald J Kabat | Direktur | 6 Maret 2018 F | 10.874 | 0 | 0 | $0 |
| Louis W Sullivan | Direktur | 31 Maret 2016 A | 14.096 | 0 | 0 | $0 |
| Norman S Matthews | Direktur | 31 Maret 2016 A | 12.890 | 0 | 0 | $0 |
| Karyn Mashima | Direktur | 10 Maret 2014 F | 19.269 | 0 | 0 | $0 |
| Irving Shafran | Direktur | 20 Nov. 2003 S | 750.000 | 0 | 0 | $0 |
| Stanley M Bergman | · | 26 Mei 2026 G | 253.279 | 0 | 5 | $-7.544.687 |
| Kurt P Kuehn | · | 10 Maret 2026 S | 15.420 | 0 | 1 | $-224.562 |
| Deborah Derby | · | 6 Maret 2026 A | 15.093 | 0 | 0 | $0 |
| Joseph L Herring | · | 6 Maret 2026 A | 30.325 | 0 | 0 | $0 |
| Margaret A Hamburg | · | 20 Mei 2009 M | 0 | 0 | 0 | $0 |
| Pamela Joseph | · | 16 Nov. 2004 S | 98.879 | 0 | 0 | $0 |
Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka
Kepemilikan ETF Dimiliki oleh 86 ETF
Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.
| Dana | Bobot | Unit | Per tanggal | Sumber |
|---|---|---|---|---|
| RSPH · Invesco Exchange-Traded Fund Trust | 1,56% | 162.140 SH | 1 Okt. 2026 | Harian |
| GURU · Global X Funds | 1,29% | 9.179 NS | 31 Juli 2026 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 0,87% | 106.077 NS | 31 Juli 2026 | N-PORT |
| RPV · Invesco Exchange-Traded Fund Trust | 0,64% | 125.073 SH | 1 Okt. 2026 | Harian |
| FBCV · FIDELITY COVINGTON TRUST | 0,36% | 7.509 NS | 31 Juli 2026 | N-PORT |
| JPME · J.P. Morgan Exchange-Traded Fund Tr… | 0,33% | 18.150 NS | 31 Juli 2026 | N-PORT |
| IQSM · New York Life Investments ETF Trust | 0,33% | 12.855 NS | 31 Juli 2026 | N-PORT |
| PKW · Invesco Exchange-Traded Fund Trust | 0,28% | 54.791 SH | 1 Okt. 2026 | Harian |
| BKMC · BNY Mellon ETF Trust | 0,23% | 17.140 NS | 31 Juli 2026 | N-PORT |
| DFAT · Dimensional ETF Trust | 0,22% | 364.767 NS | 31 Juli 2026 | N-PORT |
| FSMD · FIDELITY COVINGTON TRUST | 0,20% | 57.583 NS | 31 Juli 2026 | N-PORT |
| RSP · Invesco Exchange-Traded Fund Trust | 0,20% | 2.223.555 SH | 1 Okt. 2026 | Harian |
| DFAS · Dimensional ETF Trust | 0,19% | 343.006 NS | 31 Juli 2026 | N-PORT |
| ESML · iShares Trust | 0,18% | 58.607 SH | 11 Sep. 2026 | Harian |
| BBMC · J.P. Morgan Exchange-Traded Fund Tr… | 0,17% | 41.019 NS | 31 Juli 2026 | N-PORT |
| VBR · VANGUARD INDEX FUNDS | 0,17% | 1.416.056 SH | 19 Agu 2026 | Harian |
| FNX · First Trust Exchange-Traded AlphaDE… | 0,15% | 24.666 NS | 31 Juli 2026 | N-PORT |
| FNK · First Trust Exchange-Traded AlphaDE… | 0,15% | 3.879 NS | 31 Juli 2026 | N-PORT |
| IYH · iShares Trust | 0,14% | 57.526 SH | 11 Sep. 2026 | Harian |
| NUSC · Nushares ETF Trust | 0,14% | 20.654 NS | 31 Juli 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,12% | 46.652 NS | 31 Juli 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,12% | 293.098 SH | 19 Agu 2026 | Harian |
| SMMD · iShares Trust | 0,12% | 52.697 SH | 11 Sep. 2026 | Harian |
| IXJ · iShares Trust | 0,11% | 51.636 SH | 11 Sep. 2026 | Harian |
| VB · VANGUARD INDEX FUNDS | 0,10% | 2.230.411 SH | 19 Agu 2026 | Harian |
| CURE · Direxion Shares ETF Trust | 0,10% | 1.905 NS | 31 Juli 2026 | N-PORT |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,09% | 8.644 SH | 1 Okt. 2026 | Harian |
| VFMF · VANGUARD WELLINGTON FUND | 0,09% | 7.550 SH | 19 Agu 2026 | Harian |
| IWS · iShares Trust | 0,08% | 146.411 SH | 10 Sep. 2026 | Harian |
| TILT · FlexShares Trust | 0,08% | 20.224 NS | 31 Juli 2026 | N-PORT |
| WSML · iShares Trust | 0,08% | 6.020 SH | 11 Sep. 2026 | Harian |
| VFVA · VANGUARD WELLINGTON FUND | 0,07% | 7.214 SH | 19 Agu 2026 | Harian |
| RWL · Invesco Exchange-Traded Fund Trust … | 0,07% | 77.197 SH | 1 Okt. 2026 | Harian |
| JVAL · J.P. Morgan Exchange-Traded Fund Tr… | 0,07% | 6.494 NS | 31 Juli 2026 | N-PORT |
| IWR · iShares Trust | 0,06% | 403.437 SH | 11 Sep. 2026 | Harian |
| DFUV · Dimensional ETF Trust | 0,06% | 98.929 NS | 31 Juli 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,05% | 13.423 NS | 31 Juli 2026 | N-PORT |
| XOEF · iShares Trust | 0,05% | 125 SH | 11 Sep. 2026 | Harian |
| DFAC · Dimensional ETF Trust | 0,05% | 270.764 NS | 31 Juli 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,05% | 2.999 NS | 31 Juli 2026 | N-PORT |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0,04% | 5.039 SH | 1 Okt. 2026 | Harian |
| FAB · First Trust Exchange-Traded AlphaDE… | 0,04% | 858 NS | 31 Juli 2026 | N-PORT |
| CATH · Global X Funds | 0,04% | 6.000 NS | 31 Juli 2026 | N-PORT |
| PRF · Invesco Exchange-Traded Fund Trust | 0,04% | 44.360 SH | 1 Okt. 2026 | Harian |
| DCOR · Dimensional ETF Trust | 0,03% | 13.104 NS | 31 Juli 2026 | N-PORT |
| VOOV · VANGUARD ADMIRAL FUNDS | 0,03% | 22.387 SH | 19 Agu 2026 | Harian |
| IVE · iShares Trust | 0,03% | 160.669 SH | 11 Sep. 2026 | Harian |
| IUSV · iShares Trust | 0,03% | 83.684 SH | 11 Sep. 2026 | Harian |
| CHRI · Global X Funds | 0,03% | 24 NS | 31 Juli 2026 | N-PORT |
| DSI · iShares Trust | 0,02% | 14.799 SH | 10 Sep. 2026 | Harian |
| IWD · iShares Trust | 0,02% | 218.760 SH | 11 Sep. 2026 | Harian |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0,02% | 59.466 SH | 19 Agu 2026 | Harian |
| EGLE · Global X Funds | 0,02% | 5 NS | 31 Juli 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,02% | 25.929 NS | 31 Juli 2026 | N-PORT |
| XYLG · Global X Funds | 0,02% | 132 NS | 31 Juli 2026 | N-PORT |
| TOPC · iShares Trust | 0,02% | 59 SH | 10 Sep. 2026 | Harian |
| QVML · Invesco Exchange-Traded Fund Trust … | 0,02% | 3.104 SH | 1 Okt. 2026 | Harian |
| XCLR · Global X Funds | 0,01% | 6 NS | 31 Juli 2026 | N-PORT |
| XVV · iShares Trust | 0,01% | 1.104 SH | 11 Sep. 2026 | Harian |
| PTLC · Pacer Funds Trust | 0,01% | 5.070 NS | 31 Juli 2026 | N-PORT |
| IVV · iShares Trust | 0,01% | 1.220.662 SH | 11 Sep. 2026 | Harian |
| XYLD · Global X Funds | 0,01% | 4.788 NS | 31 Juli 2026 | N-PORT |
| PBP · Invesco Exchange-Traded Fund Trust | 0,01% | 576 SH | 1 Okt. 2026 | Harian |
| DFUS · Dimensional ETF Trust | 0,01% | 30.222 NS | 31 Juli 2026 | N-PORT |
| IWB · iShares Trust | 0,01% | 68.043 SH | 11 Sep. 2026 | Harian |
| XRMI · Global X Funds | 0,01% | 70 NS | 31 Juli 2026 | N-PORT |
| SPUU · Direxion Shares ETF Trust | 0,01% | 365 NS | 31 Juli 2026 | N-PORT |
| IWV · iShares Trust | 0,01% | 27.083 SH | 9 Sep. 2026 | Harian |
| IYY · iShares Trust | 0,01% | 4.036 SH | 10 Sep. 2026 | Harian |
| QDPL · Pacer Funds Trust | 0,01% | 2.304 NS | 31 Juli 2026 | N-PORT |
| ITOT · iShares Trust | 0,01% | 123.729 SH | 11 Sep. 2026 | Harian |
| PHDG · Invesco Actively Managed Exchange-T… | 0,01% | 77 SH | 1 Okt. 2026 | Harian |
| HCMT · Direxion Shares ETF Trust | 0,01% | 674 NS | 31 Juli 2026 | N-PORT |
| VOO · VANGUARD INDEX FUNDS | 0,01% | 2.513.394 SH | 19 Agu 2026 | Harian |
| VTI · VANGUARD INDEX FUNDS | 0,01% | 3.089.160 SH | 19 Agu 2026 | Harian |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,01% | 81.658 SH | 19 Agu 2026 | Harian |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0,01% | 16.261 SH | 19 Agu 2026 | Harian |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,01% | 8.309 SH | 19 Agu 2026 | Harian |
| ESGV · VANGUARD WORLD FUND | 0,01% | 22.281 SH | 19 Agu 2026 | Harian |
| SPXL · Direxion Shares ETF Trust | 0,01% | 7.569 NS | 31 Juli 2026 | N-PORT |
| XTR · Global X Funds | 0,01% | 4 NS | 31 Juli 2026 | N-PORT |
| DFSV · Dimensional ETF Trust | 0,00% | 99 NS | 31 Juli 2026 | N-PORT |
| ISCB · iShares Trust | · | 4.208 SH | 11 Sep. 2026 | Harian |
| ISCV · iShares Trust | · | 20.757 SH | 11 Sep. 2026 | Harian |
| SMLF · iShares Trust | · | 8.316 SH | 11 Sep. 2026 | Harian |
| SMMV · iShares Trust | · | 19.508 SH | 19 Agu 2026 | Harian |
HSIC Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan
Target Harga 12 Bulan
15 analis · 2026-09-30Target rata-rata $97.27 +14,6%
Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor
Dasar FY, harga per penutupan akhir tahun fiskal terakhir setiap perusahaan.
| Ticker | Kapitalisasi Pasar | P/E | Pendapatan YoY | Margin Bersih | ROE | Margin Kotor |
|---|---|---|---|---|---|---|
| HSIC | $8.81B | 23.3 | 4.0% | 3.0% | 12.0% | 31.1% |
| MCK | $242.30B | 22.5 | 12.4% | 1.2% | -224.3% | 3.6% |
| COR | $60.61B | 39.3 | 9.3% | 0.48% | 144.3% | 3.6% |
| CAH | · | 32.9 | 14.2% | 0.67% | -60.5% | 3.8% |
| AHCO | $1.35B | -19.2 | -0.49% | -2.2% | -4.6% | · |
| ACH | · | · | · | · | · | · |
| MEDS | · | · | · | · | · | · |
Berita Terbaru Berita utama terbaru yang menyebutkan perusahaan ini
Sinyal Perdagangan Sinyal beli/jual terbaru dengan harga masuk dan rasio risiko/imbalan
Tidak ada sinyal terbuka saat ini — tidak ada kartu yang terisi, dan itu jujur.
Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap
Pilih metrik yang penting bagi Anda — klik + di sebelah baris mana pun di Fundamental Lengkap di atas.
Pilihan Anda disimpan dan mengikuti Anda di semua ticker.